RAT11 - Overview: Oxalate/Creatinine Ratio, Urine
Calculating the oxalate concentration per creatinine
MEX - Overview: Mexiletine, Serum
Assessing achievement of optimal therapeutic mexiletine concentrations Assessing potential mexiletine toxicity
MAS1 - Overview: Myelopathy, Autoimmune/Paraneoplastic Evaluation, Serum
Evaluating patients with suspected autoimmune myelopathy, myelitis, and paraneoplastic myelopathy using serum specimens
ASPBA - Overview: Aspergillus Antigen, Bronchoalveolar Lavage
Aiding in the diagnosis of invasive aspergillosis using bronchoalveolar lavage specimens Assessing response to therapy
NGCLN - Overview: MayoComplete Chronic Lymphoid Neoplasms, Next-Generation Sequencing, Varies
Aiding in establishing diagnosis, refining prognosis, and potentially identifying targeted therapies for the optimal management of patients with chronic or low-grade B-cell lymphoid neoplasms
FBLGG - Overview: Beta Lactoglobulin IgG
Beta Lactoglobulin IgG
GlycoMark
FRDG - Overview: Rhodotorula IgE
Rhodotorula IgE
MGMT - Overview: MGMT Promoter Methylation, Tumor
Prognostication of newly diagnosed patients with glioblastoma, IDH-wildtype Identifying newly diagnosed glioblastoma, IDH-wildtype patients that may respond to alkylating chemotherapy (ie, temozolomide) Guiding therapy decision making for...
SLFA - Overview: Cryptococcus Antigen Screen with Titer, Serum
Aiding in the diagnosis of cryptococcosis This test should not be used as a test of cure or to guide treatment decisions. This test should not be used as a screening procedure for the general populations.